Company Valuation: China Resources Pharmaceutical Group Limited

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,303 39,705 32,229 35,810 27,957 28,271 - -
Change - 78.03% -18.83% 11.11% -21.93% 1.12% - -
Enterprise Value (EV) 1 61,337 73,426 71,468 90,725 90,801 81,624 76,231 60,874
Change - 19.71% -2.67% 26.95% 0.08% -10.11% -6.61% -20.15%
P/E 5.92x 9.58x 7.76x 10x 6.12x 5.74x 5.37x 5x
PBR 0.44x 0.8x 0.32x 0.34x 0.48x 0.45x 0.41x 0.35x
PEG - 1x 44.15x -0.7x 0.2x 0.73x 0.78x 0.68x
Capitalization / Revenue 0.09x 0.16x 0.12x 0.13x 0.09x 0.09x 0.08x 0.08x
EV / Revenue 0.26x 0.29x 0.27x 0.33x 0.3x 0.25x 0.22x 0.17x
EV / EBITDA 4.83x 4.38x 4.65x 5.47x 4.73x 3.96x 3.58x 2.94x
EV / EBIT 6.22x 5.39x 5.98x 6.98x 6.23x 4.93x 4.32x 3.26x
EV / FCF 5.88x 7.47x 5.49x 5.73x 4.37x 46.1x 12.6x 7.27x
FCF Yield 17% 13.4% 18.2% 17.5% 22.9% 2.17% 7.92% 13.7%
Dividend per Share 2 0.15 0.16 0.1669 0.1445 0.2203 0.2054 0.2241 0.2821
Rate of return 4.23% 2.53% 3.25% 2.54% 4.95% 4.56% 4.98% 6.27%
EPS 2 0.6 0.66 0.6612 0.5677 0.7268 0.7839 0.8381 0.8998
Distribution rate 25% 24.2% 25.2% 25.5% 30.3% 26.2% 26.7% 31.4%
Net sales 1 236,806 254,106 265,229 275,999 306,131 324,714 341,354 359,370
EBITDA 1 12,690 16,775 15,382 16,601 19,202 20,599 21,289 20,736
EBIT 1 9,868 13,623 11,952 13,005 14,567 16,541 17,648 18,651
Net income 1 3,769 4,147 4,178 3,589 4,594 4,826 5,222 5,645
Net Debt 1 39,035 33,720 39,238 54,915 62,844 53,352 47,959 32,603
Reference price 2 3.550 6.320 5.130 5.700 4.450 4.500 4.500 4.500
Nbr of stocks (in thousands) 6,282,510 6,282,510 6,282,510 6,282,510 6,282,510 6,282,510 - -
Announcement Date 3/29/22 3/30/23 3/26/24 3/26/25 3/24/26 - - -
1HKD in Million2HKD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
5.57x0.25x3.92x4.7% 3.5B
35.49x12.89x26.26x0.56% 1,082B
28.11x6.46x17.57x2.03% 633B
32.2x7.69x15.73x2.65% 461B
18.2x4.52x11.11x2.93% 339B
24.21x5.06x14.18x1.72% 301B
22.23x5.7x13.76x2.76% 292B
14.65x5.43x11.14x3.42% 225B
24.39x6.45x11.36x2.7% 202B
-46.87x5.66x31.47x2.47% 163B
Average 15.82x 6.01x 15.65x 2.59% 370.32B
Weighted average by Cap. 24.74x 8.04x 18.58x 1.94%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 3320 Stock
  4. Valuation China Resources Pharmaceutical Group Limited